ISDA

Entry Detail

PDB ID:

2A8H

Keywords:

HYDROLASE

Title:

Crystal structure of catalytic domain of TACE with Thiomorpholine Sulfonamide Hydroxamate inhibitor

Biological Source:

Source Organism:

Homo sapiens

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2005-07-08

Release Date:

2006-02-07

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

2.30 Å

R-Value Free:

0.28

R-Value Work:

0.21

R-Value Observed:

0.21

Space Group:

P 21 21 21

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:ADAM 17
Mutations:S266A, N452Q
Chain IDs:A, B
Chain Length:271
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P78536 Pfam ID:PF13688 EC:3.4.24.86

Ligand Molecules

4NH

Primary Citation

Acetylenic TACE inhibitors. Part 3: Thiomorpholine sulfonamide hydroxamates.

Levin, J.I, Chen, J.M, Laakso, L.M, Du, M, Schmid, J, Xu, W, Cummons, T, Xu, J, Jin, G, Barone, D, Skotnicki, J.S, Cowling, R, Barone, D, Black, R.A, Skotnicki, J.S.Show

Bioorg.Med.Chem.Lett. 16 1605 1609 (2006)

PMID: 16426848 DOI: 10.1016/j.bmcl.2005.12.020

Abstact

A series of thiomorpholine sulfonamide hydroxamate TACE inhibitors, all bearing propargylic ether P1' groups, was explored. In particular, compound 5h has excellent in vitro potency against isolated TACE enzyme and in cells, oral activity in a model of TNF-alpha production and a collagen-induced arthritis model, was selected as a clinical candidate for the treatment of RA.

Legend

Protein

Chemical

Disease

Primary Citation of related structures